Interferon-alpha FDA Link

One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.

Also Known As:

Interferon Alfa; Glaxo Wellcome Brand of Interferon alfa-n1; Interferon Alfa-n1; Interferon Alfa-n3; Interferon, Lymphoblastoid; Interferon, alpha; Wellferon; Glaxo Wellcome Brand of Interferon alfa n1; Interferon Alfa n1; Interferon Alfa n3; Interferon alpha; Leukocyte Interferon; Lymphoblast Interferon; Lymphoblastoid Interferon; alpha Interferon; Interferon, Leukocyte; Interferon, Lymphoblast; alpha-Interferon

Pharmalogical Action Categories:

Antiviral Agents
Immunologic Factors

-

Amino Acids, Peptides, and Proteins

-

Proteins: 58433

-

Intercellular Signaling Peptides and Proteins: 9177

-

Cytokines: 34131

-

Interferons: 16651

-

Interferon Type I: 688

*

Interferon-alpha: 9450

-

Interferons: 16651

-

Interferon Type I: 688

*

Interferon-alpha: 9450

-

Peptides: 16375

-

Intercellular Signaling Peptides and Proteins: 9177

-

Cytokines: 34131

-

Interferons: 16651

-

Interferon Type I: 688

*

Interferon-alpha: 9450

-

Interferons: 16651

-

Interferon Type I: 688

*

Interferon-alpha: 9450

-

Biological Factors: 931

-

Intercellular Signaling Peptides and Proteins: 9177

-

Cytokines: 34131

-

Interferons: 16651

-

Interferon Type I: 688

*

Interferon-alpha: 9450

-

Interferons: 16651

-

Interferon Type I: 688

*

Interferon-alpha: 9450

P Posteraro Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)